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Abstract
North American bison have rebounded from near-extinction in the nineteenth century but from such small inbred founding populations 
that once-rare deleterious nuclear gene alleles and mitochondrial haplotypes are now be at high frequencies. The initial bottleneck was 
compounded by decades of unnatural selection affecting bison conservation genomics and undercutting restoration initiatives. The 
genomics era began in late 2010 for bison and sister species yak with the release of 102 whole mitochondrial genomes, displacing 
earlier control region and microsatellite data not extending to coding regions. This allows detection of both sporadic and sub-clade 
level mutations in mitochondrially encoded proteins and tRNAs by comparative genomics methods: deleterious mutations in both 
cytochrome b (V98A) and ATP6 (I60N) occur within a single common bison haplotype. Since similar mutations in human and dog 
cause clinical impairment of mitochondrial oxidative phosphorylation, these bison are predicted significantly impaired in aerobic 
capacity, disrupting highly evolved cold tolerance, winter feeding behaviors, escape from predators and competition for breeding. 
Because Yellowstone National Park bison are subjected to genetically uninformed culls and surplus animals used to seed new 
conservation herds, mutational status has significant implications. Continuing take of the remaining bison with wildtype mitochondria 
may recapitulate errors of nineteenth century bison stewardship bringing bison conservation to the point of no return.
Introduction
Recovery of a species from a severe bottleneck requires consideration of both nuclear and mitochondrial genomics (1, 2) because 
inbred reduced populations may have lost much of their former genetic diversity and harbor unnaturally high frequencies of 
deleterious alleles (3). Inbreeding depression in Florida panthers (4), collapse of the pygmy rabbit captive breeding program (5), 
facial tumors in tasmanian devil (6) and required rescue of the Texas State Bison Herd (7) have put such concerns on center stage.
In the case of bison, natural selection has not been fully operative on deleterious alleles for decades, having been largely displaced 
by predator control, genetically uninformed culls, trophy bull hunts, winter hay feeding, and selection for docility. Recovery of large 
herds of animals outwardly resembling bison serves no authentic conservation purpose if these bison are hobbled by inherited 
disease and no longer function as they had evolved up to the era of human interference.
Genetic isolation of small bison populations has been mitigated in the past by animal exchanges but these have sometimes spread 
tuberculosis and brucellosis (8) and brought in descendants of hybridization experiments with domestic cattle (9). The focus today is 
restoration of pre-settlement bison genetic diversity without inadvertent spread of inherited disease (1). 
For the nuclear genome, the 1000 Human Genome Project concluded (10) that each individual human nuclear genome carries 275 
loss-of-function variants and 75 variants previously implicated in inherited disease (both classes typically heterozygous), 
additionally differing from the reference human proteome at 10,488 non-synonymous sites. The deleterious alleles include 200 in-
frame indels, 90 premature stop codons, 45 splice-site-disrupting variants and 235 deletions shifting reading frame. In bison, in view 
of the recent extreme bottleneck and subsequent small herd size history, the overall genetic load should be worse, with deleterious 
nuclear genes more commonly homozygous. 
Based on extensive clinical testing, a recent study estimates that 1 in 5000 human live births has inherited mitochondrial disease, 
with an additional 1 in 200 asymptomatic carriers (11), subject to the complexities of heteroplasmic inheritance of mitochondrial 
genomes discussed below. Bison mitochondrial genomes may be affected at even higher frequencies; indeed, significant anomalies 
in mitochondrial gene products have already been reported (2).
The limited assessments of bison genetic status provided by sequencing functionally uninformative regions (homopolymers, control 
regions, synonymous and non-coding SNPs) have been superseded by direct sequencing of whole nuclear and mitochondrial 
proteomes. The cattle nuclear genome was released in October 2007 and soon assembled, aligned and refined (12-14); yak and water 
buffalo genome are underway (15) and bison proposed. 
Mitochondrial genomes are available for over 214 species of mammals (16), sometimes in high multiplicities for individual species. 
This multiplicity allows rare private polymorphisms and features of small clades to be distinguished from an appropriate reference 
(or inferred ancestral) genome. Certain mitochondrial genes have been separately sequenced, with over 5,000 GenBank entries for 
1,250 mammalian species in the case of cytochrome b. For ancient DNA, some 44 control region sequences are available from fossil 
bison and 298 for extinct steppe bison (17). Whole genome sequencing from a frozen carcass is feasible but not yet begun (18). 
Data availability is thus quite favorable for comparative genomics though mitochondrial DNA evolves quite rapidly diminishing the 
utility of distant outgroups. However the phylogenetic tree is well-established for close-in pecoran ruminants, with ((((bison, steppe 
bison), yak), cow), water buffalo) the relevant phylogenetic tree topology here (43). 
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Below, analysis of complete bison mitochondrial genomes in this comparative genomics context establishes that a widespread bison 
haplotype carries substitutions in both cytochrome b (V98A: valine at position 98 changed to alanine) and ATP6 (I60N: isoleucine at 
position 60 changed to asparagine). Both variants are unambiguously deleterious according to numerous bioinformatic criteria and 
clinical observations in other species; together they strongly imply that these bison are affected by significant mitochondrial disease.
Methods
Relevant GenBank entries were acquired by Blastn of reliably annotated seed sequence queries. Some entries needed re-curation 
when the mitochondrial DNA arose from hybridization with another species (such as GenBank accession AB177774). Other entries 
were not adequately annotated by haplotype, herd origin, or domestication status in the accompanying publication. Entries lacking 
bison source data (or journal publication) has diminished value but was still used after quality control. Older GenBank entries 
containing multiple alignment anomalies were discarded as sequencing or submission error. It is difficult to distinguish between 
sporadic mutation implied by a single sequence from outright sequencing error when raw read data is not deposited at GenBank and 
indeed may not have been saved. Exceptional outcomes are rarely validated by re-sequencing (46).
Wild cattle such as gaur and banteng and fossil aurochsen data were used in place of modern domestic cattle breeds to improve 
reconstruction of ancestral sequence nodes and bison mitochondrial protein assessment because inbred domestic cattle have 
numerous derived characters (13, 14).
Sequence data never submitted to GenBank, such as the control region sequence fragments for Yellowstone and Grand Teton 
National Parks bison located in an unpublished but approved 2007 dissertation (19), was accepted after passing quality review; 
haplotypes were mapped into current whole genome based nomenclature (reference 2 and Table 8).
Haplotype re-mapping was also conducted for ancient bison DNA but not for extinct steppe bison because of sequence divergence 
and DNA damage possibly resulting in sequence error (17, 20, 21). However alignment of steppe bison DNA at cytosines strictly 
conserved in extant yak and bison did not exhibit the expected excess of C to T transitions resulting from putative postmortem 
cytosine deamination, though alignment indel abundances are compatible with a substantial error rate in homopolymer run length 
determination (data not shown). Full length mitochondrial genomes from steppe bison are very relevant to contemporary bison 
conservation genomics but none had been posted to GenBank as of January, 2011.
Fasta headers of sequences directly downloaded from GenBank begin with uninformative accession numbers, yet alignment 
programs are generally restricted as to the number of characters displayed. As this leads to unintelligible output in alignments of 
thusands of sequences from multiple species, headers were replaced with a simple flat database of concatenated attributes such as 
genus, species, haplotype, domestic, wild, and disease allele status.
NCBI provides the main gateway to sequence data via Blast servers (61). While the algorithm itself is stable, formatting options are 
not. Understanding these is critical when querying mitochondrial gene products because the enormous amount of available data 
overwhelms current display capacity. This causes shorter sequences from bison and yak to score lower than longer sequences from 
diverged species and even nuclear numts, resulting in their loss in output. This can be partly remedied by a careful choice of query, 
setting the hidden output parameter to its current maximum of 20,000 matches, and making full use of taxonomic inclusion and 
exclusion settings. This still does not address GenBank entries filed under the wrong taxon, a serious issue when hybridizations was 
not recognized at the time of sequence submission, resulting in spurious genetic diversity when interpreted by a bioinformatics 
pipeline.
Output format from a Blast query were manually adjusted to raise the default to the maximum number of alignments allowed, 
withthe ‘alignment view’ option re-set to ‘flat query anchored with dots for identities’ because this accommodates indels in either 
query or matches, reducing clutter by exhibiting only differences relative to the query. However to speed Blast searches, GenBank 
now collapses multiplicities into single precomputed matches in the original output (that is, identical sequences -- even from 
different species -- are represented by a single proxy). Those multiplicities are lost upon reformatting but can be captured by using 
the taxonomy link from the initial output.
Because output line width is restricted to 80 characters even for a 16,000 base pair whole genome query, this may result in hundreds 
of screens of output, almost all dots. To extract information, output was reformatted into a single row and columnized at each 
position using a desktop spreadsheet or after realignment of collected accessions in Multalin (22) set at one character break. 
Uninformative columns can be moved aside or deleted and the manageable remainder assessed for phylogenetic characters, 
haplotype classification, or amino acid variational statistics (reduced alphabet). This approach is far easier to adjust after a formatting 
change is made at NCBI than a formal mining algorithm code.
The new ‘find related data’ feature at GenBank proves critical to managing thousands of accession numbers -- a central issue in 
bioinformatics because ten thousand vertebrate genomes are being deposited, each with twenty thousand coding genes (15). A long 
list of match accessions can be recast as species multiplicities for a non-redundant list of taxa, ordered in a provided phylogenetic 
tree. Similarly, all PubMed publication identification numbers associated with the accessions can be requested, allowing quick 
recovery of all applicable journal abstracts and those with open access. The thirteen proteins from thousands of mammalian 
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mitochondrial genomes can be extracted into fasta format and recompiled as separate sets with a database sort on the header. tRNA 
compilation still requires screen scrapes or complicated grep procedures -- however these have been conveniently compiled 
elsewhere (25).
Multalin proved to be the most useful online alignment program (22) because it accepts very large input databases, allows arbitrary 
display widths, optionally maintains input order, allows character separation and an option to display all residues or only differences 
relative to a canonical first sequence.
Bison and yak tRNA variations were evaluated using MitoMap (33), which maintains a complete list of human tRNA mutations and 
associated disease, and the curated phylogenetic tRNA dataset Mamit (23). Comparative genomics takes a few twists because 
mammalian mitochondrial tRNAs evolve quite rapidly in comparison to nuclear tRNAs. Generalized nucleotide alignment programs 
do not reliably place gaps, in part because they do not recognize -- or anchor the alignment to -- reverse complementary stem base 
pairs and other non-local constraints. Even if they did, homological (evolutionary descent) alignment may differ from cloverleaf-
based structural alignment. Parsing tRNA sequences into standard folding cloverleaf subdomains and reverse-complementing one 
member of each stem pair allows a single difference alignment to display all exceptions to stem base pairing. This proved not 
indicative of mitochondrial disease because presumptive wildtype mitochondrial tRNAs in many species already show imperfect 
base pairing.
Seven methods are used here to classify observed amino acid variation in bison and yak mitochondrial proteins as either dysfunctional, 
near-neutral, or potentially adaptive. While non-synonymous SNP interpretation never attains 100% sensitivity and selectivity, the 
massive data set of mitochondrial proteins (12,603 sequences in 1,637 mammals utilized for cytochrome b) and relatively slow 
evolution (83% identity between bison and platypus) favor reliable interpretation. Prediction accuracy -- as tested on clinically and 
biochemically validated human disease alleles -- is very high on the moderate to radical change at conserved sites considered here (31, 
32). 
1. Validity of the amino acid substitution: the reported change may be an artifact when an older sequencing technology is used or read 
coverage is low, when ambient DNA base composition is anomalous or a homopolymer read length error could occur, when too-
complex a mutation is required to produce the substitution, when ambiguity in base determination occurs elsewhere in the submitted 
sequence, when multiple anomalous substitutions are reported within the same animal, when nuclear pseudogenes (numts) and 
hybridization with another species are not considered, or when no re-sequencing or raw read reevaluation is reported in the case of a 
surprising change in a large population survey of inbred animals.
2. Unique aspects of mitochondrial disease: the inheritance of the mitochondrial genome is quite different from that of nuclear genes 
because of heteroplasmy, undercutting decades of assumptions in population genetics (60), challenging the accuracy of that data 
(47-49), and here affecting methods for associating amino acid variation with mitochondrial disease:
• Mitochondrial DNA is maternally inherited in bison. The bull may carry mitochondrial mutations or even whole cattle 
mitochondria but these do not pass on to descendants (negligible paternal leakage). On the other hand, cattle mitochondrial 
DNA from a distant hybridization persists indefinitely without dilution or fragmentation despite subsequent backcrosses to 
bison. 
• Each maturing bison oocyte has some 260,000 copies of mitochondrial DNA with up to ten copies in a single mitochondrion 
(24). These may differ in initial sequence (heteroplasmy) and acquire additional differences over time which are not shuffled 
onto composite haplotypes because of the effective absence of recombination. 
• Replication occurs unevenly in maturing oocytes as does subsequent stochastic segregation of mitochondria to generations of 
daughter cells and later mitochondrial replication in descendent stem cells. Post-natal selection may affect haplotype ratios. A 
disease haplotype, initially rare and functionally compensated by healthy haplotypes, can surge either ontogenetically (causing 
late disease onset in a somatic cell lineage) or phylogenetically (leading to effective inheritance in descendants and earlier 
onset) within a single generation, a haplotype bottleneck effect.
• Bison DNA sequences reported to GenBank do not originate from oocytes but rather from blood, muscle, skin, hair, or 
intestinal sloughing. Although heteroplasmy implies these tissues should often contain multiple haplotypes, only one haplotype 
per sample has ever been reported for bison, with the rest apparently discarded as sequencing or cloning error. In contrast, 
recent careful re-sequencing of a 6,738 year old aurochs established a single heteroplasmic control region site (59). 
Consequently bison data does not directly report on oocyte haplotype abundances nor predict disease status of either parent or 
descendants. This applies in particular to sporadic mutations reported for a single animal (which could equally be sequence 
error, somatic mutation, or heteroplasmic surge). However when a substantial sub-clade with a given set of amino acid 
variations is inherited over many generations, that provides evidence for complete oocyte penetration of that haplotype and 
conventional inheritance of the amino acid change in all descendants. On the other hand, frameshift and internal stop codon 
mutations -- lethal because oxidative phosphorylation is essential -- imply internal compensation by unreported wildtype 
haplotypes must be occurring at a significant level given the essentiality of oxidative phosphorylation.
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• The mutation rate in mitochondria is some tenfold higher than in chromosomal DNA, often attributed to reactive oxygen 
species generated by oxidative phosphorylation, sub-optimal functioning of imported nuclear replication and repair genes or 
lack of protective histones (26). Mutational hotspots may also exist because of local base compositional anomalies, 
homopolymer run susceptibility or regional propensity to fold into tertiary structures. Despite this, observed recurrent mutation 
is rare in protein coding regions: the same amino substitution seldom arises de novo in oocyte DNA, much less rises from low 
heteroplasmy status to full heritability, as seen from human mitochondrial disease statistics (27) and the lack of phylogenetic 
reoccurrence in unrelated clades despite voluminous data (next section). This implies most observed amino acid substitution in 
bison arose from unique events and their presence today in descendants is phylogenetically informative.
• If multiple haplotypes in a population happen to wax and wane across a species divergence, the resulting mitochondrial lineage 
sorting could give a quite different phylogenetic tree of that from nuclear genes, an issue compounded by small sampling sizes 
chosen for sequencing. Mitochondrial heteroplasmic persistence and resurgence makes the determination -- indeed definition -- 
of amino acid ancestral state somewhat problematic. It further complicates establishment of the reduced alphabet (set of fully 
functional amino acids at a given position) which may drift over time according to clade because of varying co-evolving 
residues. 
• Functional compensation can occur if single mitochondrion carries multiple haplotypes, one of them wildtype which can arise 
via mitochondrial fusion if not initially present. Compensation by a nuclear genes imported into mitochondria may occur in 
yeast (28). Non-compensable mitochondria may turn over more rapidly or replicate more slowly (be selected against). These 
considerations make it very difficult to predict the impact on oxidative phosphorylation of a deleterious variation in a 
mitochondrially encoded protein unless only this haplotype class occurs in the cell and the amino acid substitution is at a site 
not physically interacting with or influenced by any nuclear gene product. Cytochrome b resides in the bc1 complex which 
involves 11 gene products, all but one nuclear encoded. Thus a bison cytochrome b variation cannot be internally compensated 
nor by a secondary variant of ATP6 (or any other mitochondrially encoded protein). Compensation by an altered nuclear gene 
could give another form of mitochondrial disease when cross-matched with a conventional bison mitochondrial haplotype.
• Despite these opportunities for compensation, it is rarely observed experimentally except as yeast petite suppressors (billions of 
cells plated out under strong selection, bison populations in the thousands). Mitochondrial disease is surprisingly common in 
species far less inbred than bison: 
“One in 4000 individuals is at risk of developing a mitochondrial disease sometime in their lifetime. Half of those 
affected are children who show symptoms before age five, and approximately 80% of them will die before age 20. 
The mortality rate is roughly that of cancer... The mutation rate of the mitochondrial genome is 10–20 times 
greater than of nuclear DNA, and mtDNA is more prone to oxidative damage than is nuclear DNA. Mutations in 
human mtDNA cause premature aging, severe neuromuscular pathologies and maternally inherited metabolic 
diseases, and influence apoptosis (29)." [WC Copeland: Chief, Laboratory of Molecular Genetics, NIH]
3. Physical-chemical nature of amino acid change: statistics drawn from millions of amino acid changes studied over the last sixty 
years (30) in conjunction with in vitro assessment of the resulting protein and correlation to clinical disease status show mild 
changes in properties such as hydrophobicity, polarity, charge, aromaticity, branched side chains, hydrogen-bonding and disulfide 
capacity, and beta sheet, 3-10 turn or alpha helix forming or ending propensity are vastly less probable to give rise to dysfunctional 
protein than radical substitutions. This conservatism is reflected in mitochondrial genetic code in that the most common form of 
mutation often give no change at all (synonymy) or cause a mild change (same cell, row or column). The risk that substitutions 
cause protein dysfunction can be quantitated by Grantham distances, Blosum matrices, or the more recent SIFT and PolyPhen2 
algorithms used in part here (31). The latter relies on a curated protein sequence and structural data set covering only a small 
fraction of available GenBank data and that out of phylogenetic tree topological context (e.g. sea urchin proteins are not equally 
relevant as cow to bison). 
4. Comparative genomics: amino acids vary greatly in their tolerance of substitutions according to site position within the protein and 
its importance to function, correlating with selective pressure to maintain it. Should a peptide containing the residue be post-
translationally removed and degraded, there may be no constraints whatsoever provided by the physical-chemical nature of the 
substitution. At the other extreme, a residue critical to an enzyme active site tolerates no change at all over trillions of years of 
observable branch length. Most site positions are intermediate, allowing mild change as defined by a restricted alphabet specific to 
that site via comparative genomic alignment, along the lines of phylogenetic tree-aware TreeSAAP (32). Most nsSNPs involve a 
single nucleotide change with transitions predominating over transversions. If an amino acid change -- mild or not -- is a mere 
transition away from a conserved residue yet never observed in thousands of species despite a high mutation rate, it likely has arisen 
numerous times but never attained a foothold because selective pressure eliminated it (when drift alone did not), even as other 
reduced alphabet changes did get fixed in the same protein. Homoplasic recurrence of the change elsewhere in mammals are 
detected here via clade pattern analysis: if the change does occur uncommonly elsewhere, are these concentrated in sub-clades 
(indicating persistence and so fitness for reduced alphabet) or scattered randomly in the taxonomic sense (indicting unfixed recurrent 
mutation). This sharpening provided by clade pattern analysis -- quantitated by supportive branch length summing -- becomes 
critical as the amount of data becomes astronomical. Although moderate frequency of a polymorphism is sometimes used in medical 
genomics to argue against deleterious nature, that is not applicable here because of the founder effect and subsequent inbreeding in 
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bison, in effect making them the counterpart of a inherited disease pedigree; allele frequency is in fact extremely low when taken in 
the comparative genomics sense.
5.  Protein structure: amino acid changes can be placed within a high resolution x-ray structure of a homologous protein (or domain) 
when available at PDB. No such data is directly available for bison or yak proteins, but quite commonly for cattle. In such cases, it 
may be possible to interpret the structural significance of a substitution in terms of correct folding, protein stability, interactions with 
other residues in the same or hetero-oligomeric partners and evaluate in silico the impact of the substitution on stability energetics 
by molecular dynamics simulations. High sequence conservation (bison to cow) and extreme fold conservation allows reliable 
annotation transfer. Surprisingly few of the thirteen mitochondrially encoded proteins have any match whatsoever (Blastp against 
PDB), cytochrome b and cytochrome oxidase components being the exceptions. The latter are irrelevant because no bison variation 
occurs in them (next section). The best match of bison ATP6 -- to the E. coli crystallographic structure 1C17 -- is uninformative 
because of excessive divergence.
6. Orthologous disease transfer: a comparable allele to a bison variation may have been previously studied in human mitochondrial 
disease with direct biochemical and clinical assessment of disease phenotype. The outcome of thousands of such studies are 
tabulated at the MitoMap web site (33). Additional data from veterinarian studies of mitochondrial disease is compiled at OMIA 
(34). The bison alleles considered here do not have exact counterparts. Even if they did, divergence elsewhere in the primary 
sequence would preclude direct interpretative transfer. However the bison variant V98A of cytochrome b corresponds in 
orthologous position to canine V98M. Affected Shetland sheepdogs have significant mitochondrial disease (35). Since alanine is a 
more extreme substitution than methionine for branched chain aliphatic valine, V98A bison are predicted to be similarly impaired. 
Unlike nuclear genes, the many hundreds of known human mitochondrial disease alleles -- dispersed over 13 different proteins and 
22 tRNAs -- all present with related phenotypes despite different nomenclatures such as lactic acidosis, cardiomyopathy, exercise 
intolerance. The outcome of all mutations is the same: impaired oxidative phosphorylation. This is the case for all 21 human disease 
alleles of ATP6 (33), none of which correspond to position 60 of bison I60N. However specifics of human disease manifestation 
vary because of heteroplasmy -- different cell lineages affected at different stages of development, altering location and age of 
disease onset (29). Putative disease alleles in bison need direct biochemical validation; that could be provided rom bison muscle 
biopsies bythe same laboratories that routinely evaluate human mitochondria (35).
7. Experimental model systems: yeast and hamster cell lines provide surprisingly relevant model systems (28, 37-39). Mutant alleles of 
human genes are knocked into the nucleus, suitably altered to use the nuclear gene translation table and carry mitochondrial 
targeting signals, with mitochondrial transcription of the competing homolog knocked down by ethidium bromide. This results in a 
heterologous oxidative phosphorylation system (allotopic expression) of one human protein interacting with 12 mitochondrial and 
many nuclear proteins from the other species. Because little has changed in oxidative phosphorylation over the last billion years, 
this characterizes structural and functional attributes of known mutations despite heterologous protein-protein interactions. The 
yeast or hamster system could be adapted to specifically study the effect of mutations in bison mitochondrial proteins to supplement 
strictly bioinformatic methods reported here.
8. The accuracy of SNP interpretation is high but still imperfect. The rate of false positives is routinely estimated by blinded prediction 
of allele status of intensively studied human genes such as hemoglobin, cystic fibrosis, and rhodopsin where large numbers of 
variants from patients, controls and large scale SNP surveys have been clinically evaluated (31 and references therein). Accuracy 
can exceed 90%, with errors overwhelmingly concentrated in borderline changes in amino acid physical-chemical properties (32). 
Methods used here on bison V98A and I60N were validated using unblinded test suite of known pathogenetic mutations in human 
cytochrome b and ATP6 (51). In the special case here of two significant but not catastrophic changes in two mitochondrial proteins 
in different non-complementing oxidative phosphorylation complexes with demonstrated heritability (low or no wildtype 
heteroplasmy), prediction accuracy in the mitochondrial disease setting can be conservatively estimated as the complement of the 
probability of both being innocuous: 1- (1 - 0.85)(1 - 0.85) = 98%.
9. Fossil bison DNA represents an important control because animals operating under the full force of natural selection are not 
expected to exhibit high levels of deleterious alleles. Here 44 fossil bison control region sequences are available at GenBank (17). 
Note these have widely variable Holocene dates and do not represent a population sample in the sense of contemporary bison data.
Results
Bison sequencing effort initially focused on control region polymorphisms, homopolymer run lengths (microsatellites), and 
determination of base at primarily intergenic SNPs (43), data perhaps relevant to overall genetic diversity and past hybridization but 
not to proper functioning of the 20,000-odd nuclear and mitochondrial genes where the bison genetic burden can be expected to be 
far worse than in less inbred species which are already serious enough (10). Steppe bison could be helpful here but only the last 33 
bp of tRNA Pro are available (eg AY748559). Since the entire tRNA pro is identical in all bison and yak, the observed 100% identity 
of steppe bison comes as no surprise. There is additional sporadic variation but this probably arises from dna damage that affects 
sequencing accuracy.   
However new population-level sequencing of yak (40-42) and bison whole mitochondrial genomes (2) now makes it feasible to 
search for mitochondrial disease in these species. Indeed, Douglas and coworkers note an alarming number of anomalies and the 
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possibility of mitochondrial dysfunction in bison (2), no surprise given the historic bison bottleneck, subsequent inbreeding in small 
founder herds, restriction of gene flow between herds, and decades of unnatural selection (3,7) given the high incidence of 
mitochondrial disease in other mammals (29, 50).
Here, variation in all 13 mitochondrially encoded proteins and 22 tRNAs in all published bison and yak mitochondrial genomes 
(Table 1) was collected and evaluated by comparative genomics and comparison to human mutational databases (see methods 
section). Extensive data both from bison and yak and their immediate outgroups (wild cattle, water buffalo) proved necessary to sort 
out sporadic private variation affecting individual animals from variation affecting whole subclades and to assign synapomorphies 
(derived characters relative to ancestral state) to the appropriate lineage using the known ruminant phylogenetic tree (43). 
Thus a variation in bison with respect to cattle is not a bison mutation issue if yak and water buffalo outgroups are in concordance 
with bison but instead the ancestral value. Should only yak support bison, again the variation is not plausibly a mutation because of 
fixation and persistence over millions of years in the face of natural selection but better viewed as a shared synapomorphy of these 
sister taxa.
As a byproduct of this investigation, informative synapomorphies of Bos taurus were found shared in every case by all other species 
of wild cattle (Tables 1, 2), establishing that neither banteng (Bos javanicus) or gaur (Bos gaurus) should be allied with bison + yak 
in contrast to a weakly supported outcome from a nuclear bead chip SNP array (43). It is not at all unusual for nuclear and 
mitochondrial phylogenies to differ. Using the latter, the taxonomic incongruity of yak nomenclature (Bos grunniens sistered to 
Bison bison) is easily remedied by a change to Bison grunniens (or Poephagus grunniens). Note that the divergence of bison and 
cattle exceeds that of bison and yak, taken as 2.5 myr after reviewing fossil evidence and prior estimates (40), so distinction by 
genus is warranted both by time of divergence and extent of accrued divergence.
Mitochondrial disease can results from tRNA mutations (33) through inefficient or incorrect production of mitochondrial proteins 
with clinical symptoms variable but ultimately similar to protein mitochondrial disease as both affect oxidative phosphorylation. 
Bison and yak tRNAs differed at 11 sites in 9 tRNAs though Pro, Trp, Ile, Leu (CUN), and Arg tRNAs were conserved in the 102 
mitochondrial genomes considered (51). None of the tRNA substitutions had an exact counterpart to any linked to human 
mitochondrial disease; the degree of overall sequence divergence is too high in many cases for reliable annotation transfer. 
Bison have no tRNA changes that track with sub-clades, only private alleles (51). None of these affect the anti-codon loop or other 
strongly conserved domains, disfavoring the errant nuclear gene hyper-mutagenizing scenario (46). Analysis of a manually curated 
alignment of 127 species including yak and 41 other cetartiodactyls shows high natural variability at all of the affected sites, 
suggesting the substitutions may be innocuous or nearly so. Thus tRNA alleles have no implications for bison conservation genomics 
management (51).
Sporadic amino acid mutations are not heritable if they represent somatic mutation, tissue-specific surge in heteroplasmic abundance 
of a haplotype not significantly represented in their own oocytes or occur in a bull. These have little significance for herd 
conservation genomics management in contrast to deleterious variations observed in multiple animals (which rules out sequencing 
error and a sub-dominant heteroplasmy ratio). Consequently amino acid variants observed in single bison are considered further in 
supplemental material (51).
Eight of the thirteen bison mitochondrially encoded proteins lack non-sporadic coding variation in the 33 complete bison genomes 
available, namely COX1-3, ND1-3, ND4L and ND6. Yak are similar with subclade level variation in ND1, ND3, ND6, COX1, 
COX3 and ATP8. These results accord with the relative conservation of these mitochondrial proteins within mammals (44, 45) and 
are again inconsistent with an errant imported hyper-mutating nuclear gene such as POLG replicase being the source of 
mitochondrial proteome variation (46). 
However 8 sites in the remaining 5 bison proteins (9 in 7 yak proteins) do represent heritable nsSNP variation that cannot be 
explained as sequence error, somatic mutation or heteroplasmy artifact (Tables 3, 4). The nine approaches described in the methods 
section were applied in turn to each variant to distinguish between inconsequential neutral drift within the phylogenetically 
acceptable range of the site (reduced alphabet wobble), a derived adaptive shift, and structurally deleterious changes at the protein 
level.
These latter are not necessarily maladaptive because they could reflect balanced polymorphisms (eg malarial disease resistance of 
heterozygous sickle cell hemoglobin E6V nuclear gene (30), corresponding to a persistent heteroplasmy ratio in mitochondrial 
genes) or be fully compensated by co-evolving amino acid residues within the same protein or one that interacts with it (as seen for 
oxidative phosphorylation in yeast suppressors of the petite phenotype). These possibilities must be considered in evaluating a 
structurally deleterious substitution for mitochondrial disease.
The two strongest candidates for mitochondrial disease in bison are V98A in the CYTB gene (cytochrome b) and I60N in ATP6 
(ATP synthase Fo component). These are systematically evaluated below using nine quasi-independent methods.
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Neither variant can be explained by sequencing error. Both are observed in 17 whole genome determinations and targeted partial 
sequences from different laboratories. Neither occurs in a compositionally or structurally anomalous region that might be prone to 
repeated independent sequence error. Both are one-step base changes, the most common type of mitochondrial mutation.
Because both are observed in multiple animals in physically separated herds, neither somatic mutation nor heteroplasmy ratio surging 
are likely explanations. Despite high read coverage with modern sequencing technology, no heteroplasmy was reported even 
subsequent to enhanced awareness following its discovery in aurochsen (59). Although clearly heritable as the dominant heteroplasmic 
haplotype, no descendent genealogies have been directly studied: a heteroplasmy contribution from residual co-existing wildtype 
haplotypes may continue, with current limits of detection sensitivity being about 5% (46). Mitochondrial disease still results in humans 
in the heteroplasmic state (27, 29).
Both V98A and I60N represent potentially significant changes in the physical-chemical nature of the substituted amino acid not 
commonly found accepted in statistical compilations of observed amino acid changes. Valine and isoleucine are branched chain 
aliphatic residues with bulky hydrophobic side chains, typically deeply shielded in the interior of proteins (or as transmembrane 
regions) from the aqueous milieu. The side chain of alanine consists of a single small methyl substituent, that of asparagine is larger 
but strongly polar and hydrogen bonding. As substitutions, these are energetically unfavorable in typical proteins with the former 
leaving an unfilled hole and the latter disengaging a polar component from hydrogen-bonding solvent.
The site-specific context can strongly refine evaluation by the physical-chemical nature of the change alone -- not all residues operate 
under the same evolutionary constraints. Table 5 shows the outcome of very large scale comparative genomics alignment, made 
possible by thousands of GenBank entries for phylogenetically close-in mitochondrial proteins. Neither alanine or asparagine has any 
place in the normal reduced alphabet at these sites in any species -- despite the fact that both are just a simple base change away from 
the original amino acid and would not only have arisen frequently but also been fixed in some species as were changes to bona fide 
reduced alphabet elements in the same or flanking amino acids. Billions of years of branch length are sampled by the data.
Exceptions inevitably arise in massive data sets as allele frequencies sampled drop below 0.1%, matching sequence error rates 
especially for older data. Those exceptions can be objectively evaluated by examining their taxonomic coherence. In the case of both 
V98A and I60N, the exceptions are phylogenetically scattered (51) and do not form subclades indicative of acceptance into that 
subclade’s local reduced alphabet. These exceptions could instead represent somatic mutation, heteroplasmy sampling effects, or even 
an independent reoccurrence of the mutation seen in bison. All of these are expected at some level given the high incidence of 
mitochondrial disease reported from human (11).
As a further control to other variant loci of bison and yak (51), variation relative to cattle mitochondrial genomes was assessed in all 
13 mitochondrially encoded proteins of a Holocene aurochs sequenced at heteroplasmy depth (59). Here A23T in cytochrome b, T90I 
in ND5 and V55L in ND4 initially appear anomalous. However upon large-scale alignment within ruminants, all three changes are 
both common and taxonomic sub-clade coherent (51). This leaves no candidate loci for mitochondrial disease in the thirteen proteins 
of this aurochs.
In terms of structural impacts of the two bison amino acid substitutions, ATP6 and cytochrome b act in different structural complexes, 
namely the F1FO ATP synthase and complex III. These do not physically interact, implying that I60N and V98A cannot induce cross-
compensatory change. Their effects on decreased ATP production could be additive or alternatively one mutation be rate limiting 
rendering the other moot.
ATP6, like many multi-pass membrane proteins, does not have a satisfactory crystallographic structural determination. To locate I60N 
within the tertiary structure, it is currently necessary to use E. coli PDB model 1C17 for bison, even though the alignment is quite 
weak overall at 27% identity and does not extend informatively to the I60N site (Table 6A). The corresponding residue, position 108, 
lies within the second transmembrane helix (56). However this is not consistent with secondary structure of mammalian orthologs.
The secondary structure analysis of yak ATP6 (SwissProt accession Q7YCA5) shows I60N is located in a loop region connecting the 
first two transmembrane helices as it does in cattle (accession P00847). The yak protein is 97% identical to bison and has the expected 
wildtype value isoleucine at position 60. Other secondary structure prediction tools give the same result (data not shown).
Conservation within the primary sequence may have structural implications, for example periodic conservation of 3 or 4 residues 
suggests an alpha helix with one side constrained. However phylogenetic conservation of a 5 residue window on each side of I60N 
does not show a clear pattern (Table 6B). Several the residues have broad reduced alphabets while others are near-invariant. Proline, a 
helix-breaker, occurs at position 63 in the bison protein. Thus the structural implications of asparagine at position 60, which arises 
from from wildtype valine via a T --> A transversion, cannot be determined, though it is clearly a radical substitution (branched 
aliphatic hydrophobic to polar) in terms of the constraints of this site, not being seen in 1635 other mammalian ATP6 sequences 
despite numerous substitutions in position 60 and nearby residues gaining traction. 
 
The structural effect of V98A on bison cytochrome b can be assessed using the available high resolution data for the orthologous 
bovine complex (57). V98 occurs at the end of transmembrane helix B, sandwiched between six strongly conserved residues. The 
preceding residue, H97, is one of two critical axial histidine ligands to the high-potential heme. Two residues later, a strictly invariant 
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arginine R100 provides an essential salt bridge to a buried proprionate side chain of this same heme. Structural models of this region, 
adapted from previous publications (57, 58), are shown in Figure 1.
An alignment of 5000 cytochrome b sequences establishes that 99.6% of mammalian species have valine or isoleucine (and less 
commonly methionine). This cannot be because opportunities for fixation of substitutions are rare -- 18 of the 20 possible amino acids 
occur at position 62 of ATP6. V98A arises from a simple T to C transition. Thus strong selective pressure enforces the restriction to 
isoleucine and valine here.
A structural perturbation of the histidine axial ligand might change heme redox potential (optimized for the respiratory chain long 
ago); disruption of the proprionate salt bridge could affect folding, overall thermodynamic stability or production of reactive oxygen 
species. Thus it is no surprise that position 98 is under strong selection -- but why isoleucine and valine and no others?
The explanation lies in the post-beta carbon side chain, not the alpha carbon or peptide bond -- any amino acid provides these. A beta 
carbon alone cannot suffice -- in that case glycine and proline might be excluded from the reduced alphabet but nothing else. The side 
chain of alanine, the bison mutation under consideration, consists of just a methyl group. Here the complete absence of observed 
leucine at position 98 (Table 5) is informative because like isoleucine and valine, it is a branched chain aliphatic amino acid more 
similar than alanine. However the branching comes later, at the gamma carbon. This rules out insertion in the hydrophobic membrane 
milieu because leucine could do that equally well. Similarly phenylalanine, tryptophan and tyrosine do not occur at position 98, 
establishing the hydrophobicity, while necessary, is not sufficient. The reduced alphabet then consists of only isoleucine and valine 
because the constraint is a packing issue in a hydrophobic environment. Alanine is functionally unacceptable because it leaves a 
packing void that is energetically unfavorable to protein folding, stability or functionality at the axial or proprionate ligands (57).
Mutations at orthologous sites known to cause (or not) mitochondrial disease in other species can be informative, even though 
sequence divergence elsewhere in the protein means results cannot be literally carried over to bison. However establishment of 
pathogenicity and its clinical manifestation are still useful because bison are inconvenient to study in a veterinary context. 
In the case of V98A in bison cytochrome b, a very similar mutation V98M causing severe mitochondrial disease has been studied in 
dog (35). A human polymorphism V98L was found in a large scale SNP survey but the individual’s disease status (if any) was not 
determined. Mutations at fourteen other positions have been documented (27) for human cytochrome b, producing exercise intolerance 
(S35P, S151P, G290D), cardiac or skeletal muscle myopathy (G34S, G251S, N255H, G339E, multi-system disorder (Y278C), neonatal 
polyvisceral failure (S279P), and optic neuropathy from swollen ganglia (A29T, D171N, V356M). These are still relevant to bison 
V98A because at some level all mitochondrial disease affects the same process (cellular energy production via oxidative 
phosphorylation).
Another 125 human amino acid changing polymorphism of cytochrome b have been detected but rarely is a disease association ruled 
out. This is unfortunate because changes proven to be neutral could supplement the test suite provided by known pathogenetic 
mutations and allow double blinded assessment of prediction accuracy statistics. Lacking that, the first site occurrence in each 
phenotypic class (S35P, G34S, Y278C, S279P, and A29T), studied along with ATP6 described below by the same methods used here to 
assess bison V98A, all classified as pathogenic (51).
In the case of bison I60N in the ATP6 protein, no other mammal has a known pathogenic mutation or neutral polymorphism at position 
60. However pathogenic human mutations are known at twenty sites along the protein. Three sites were selected for addition to the 
methods test suite, H90Y, L156P, and L220P to represent exercise fatigue alleles (50). The reported symptoms have an uncanny 
similarity to those of cytochrome b (which resides in a separate protein complex not interacting with ATP6): exercise endurance, 
muscle weakness, ataxia, lactic acidemia, optic neuropathy, and so forth (27). Thus the phenotype for bison I60N would likely be 
similar to these and indeed to V98A.
Experimental model systems allow biochemical testing of specific mutations. These are applicable to bison but have not yet been 
applied to the specific sites considered here. However five cytochrome b sites pathogenic in human have been tested in allotopic yeast, 
including two causing exercise intolerance (S151P, G290D) and one causing skeletal muscle myopathy (G34S). These gave results 
concordant with clinical expectations despite the great divergence of human and yeast but more importantly give insight into the 
specific chain of events leading to protein malfunction, for example failure to assembly into a respiratory sub-complex. The human 
ATP6 mutation L156P brings about a 45% reduction in ATP production relative to controls (53); L217P also had reduced ATP 
production though normal coupling efficiencies (54). Hamster cell lines offer less sequence mismatch; an allotopic system there has 
evaluated L156R in ATP6x (55). These studies indicate that bison mutations V98A and I60N could reduce mitochondrial ATP 
production by a wide variety of mechanisms. Together in the same haplotype, these could be additive, synergistic, or one site be rate 
limiting and the other irrelevant in the combination. Even with a low level of residual wildtype heteroplasmy, ATP production would 
still be lowered (53).
The prevalence of bison haplotypes hosting V98A / I60N is not directly known, other than from the 32 complete whole genomes 
sequenced and fragmentary cytochrome b (and many fewer ATP6) sequences. Researchers have not generally specified whether 
bison were chosen at random for sequencing nor indicated familial relationships or even gender. Sample sizes are quite small relative 
to herd size. With older samples, the bison would not still be alive. It is thus problematic to extrapolate to overall incidence in North 
American conservation herds at this time.
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However a great deal of bison control region data exists. While not directly extendable to the coding regions of interest, the 
haplotype class defined by the control region can be mapped into the new global haplotype classes defined by whole genome 
sequencing (2). This mapping is necessarily ambiguous (one to many) given changes outside the control region are not observed and 
the full set of global haplotypes might not yet be known. 
However the five global haplotypes containing the V98A / I60N double feature, namely Bhap2, Bhap8, Bhap10, Bhap11, and 
Bhap17 in earlier terminology (2) are very similar to each other overall according to all-vs-all Blastn (Table 7), identical in the 
control region fragment commonly sequenced and reliably distinguished there from the other known global haplotypes by conserved 
diagnostic residues within positions 15894-15965 of the Yellowstone bison GU947004 (Table 8).
Thus under the assumption that the control region alone serve as a satisfactory proxy to positions 98 of CYTB and 60 of ATP6, the 
status of an additional 133 bison (44 of them fossil, only two with potential V98A I60N) can be inferred from GenBank data. 
Gardipee determined haplotypes for 179 additional bison in a 2006 masters thesis (21). The data for contemporary are combined into 
an overall estimate of 145 bison with the V98A / I60N haplotype and 34 without in Table 8 and Table 9. All 29 bison sequenced from 
Grand Tetons National Park carry the deleterious allele, as do 117 of 151 bison tested from Yellowstone (72%). Rates are much 
lower in overall bison data (42%, Table 7) and were a few percent at most in fossil bison.
The two fossil bison at issue may carry either, both or neither of V98A I60N assuming the double haplotype arose in sequential steps 
over time. These bison, dated to 170 (Anchorage AY748509) and 3250 years ago (Natural Trap Cave, Wyoming AY748518) are 
priority targets for re-sequencing as they could reflect intermediate stages in the development of the disease haplotype. Steppe bison 
control region sequences are available (17) but not easily mapped to bison haplotypes. Here too it would be valuable to sequence 
entire mitochondrial genomes.
Discussion
Applying the nine methods for evaluating amino acid substitutions, observed bison protein variants V98A and I60N are both 
predicted to have significantly sub-optimal energy production from oxidative phosphorylation. Two mutations acting synergistically 
in the same heritable haplotype strengthens the conclusion that affected bison have mitochondrial disease to an estimated 98% 
confidence (see methods). Biochemical verification of reduced ATP production by allotropic knock-in and standard laboratory 
protocols is important and feasible (36).
Mitochondrial disease is common in humans so it comes as no great surprise to find another species affected by it. The alarming 
frequency of occurrence in bison can be attributed (3, 7) to the severe bison bottleneck of the nineteenth century followed decades of 
inbreeding and suppression of natural selection. Mitochondrial disease in dog breeds has a similar history (35).
Based on the available evidence, the disease haplotype was uncommon in pre-contact bison but widespread today, affecting bison in 
numerous discrete herds including Yellowstone and Grand Tetons national parks. Ironically, Yellowstone bison are used to found 
new herds and improve genetics of existing herds. 
While symptoms of mitochondrial disease vary somewhat according to the specific mutation, the common denominator is inadequate 
ATP production from loss of oxidative phosphorylation capacity. Exercise intolerance, lactic acid buildup in blood, and ragged red 
muscle fiber can be expected in affected bison (2, 27). While not lethal at birth, these bison may be significantly impaired in escape 
from predators, winter cold tolerance, brushing snow aside for feeding, combat for breeding opportunities and similar aerobic 
activities.
If the goal in bison management is restoration of pre-contact genomics (1), then mutations in the mitochondrial genome need more 
extensive survey sequencing, direct biochemical and behavioral evaluation, genetic testing prior to culls and introductions to other 
herds and similar consideration of disease alleles in the companion nuclear genome. The nuclear genome may carry valuable genetic 
diversity (even in an animal with mitochondrial disease) but may also have very substantial genetic disease issues of its own (10).
 
To date, genetic management of bison conservation herds has largely eliminated bovine mitochondrial DNA introduced a century 
ago in hybridization experiments. Bison mitochondrial disease could also be managed away with retention of nuclear genetic 
diversity since only the latter is passed on by bulls. However this is not occurring with the present system of quasi-random culls of 
animals of unknown genetic status.
The present emphasis on genetically pure herds may be a misplaced priority if genetic disease is widespread in both nuclear and 
mitochondrial genomes of non-introgressed herds. Indeed, based on time of divergence and sequenced genomes from related 
laurasiatheres, the pre-contact bison genome will be 99% identical to nineteenth century cattle. These changes will be 
overwhelmingly concentrated in intergenic and intronic gene deserts and in synonymous sites in coding exons, with amino acid 
change primarily at intrinsically variable inconsequential sites (52). Thus a bison nuclear proteome, briefly introgressed by an 
introduced cow in 1900 and diluted for the subsequent century (7) will not exhibit a single significant change in a typical protein of 
450 residues relative to a pre-contact bison, the real issue being exacerbation of the formerly heterozygous genetic burden by 
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inbreeding, small herd sizes and genetically uninformed culls. Mildly introgressed animals may preserve important and authentic 
pre-contact genetic diversity no longer otherwise represented in extant pure bison.
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Table 1. Data set of complete cytochrome b and whole mitochondrial genome sequences used. The first two columns provides genus, 
species and common name according to NCBI taxonomy. The third column gives the number of of complete genomes; the fourth 
auxiliary cytochrome b partial sequences. Bison and yak accession numbers are provided elsewhere (2, 40).
 
Bos grunniens yak 72 53
Bison bison plains bison 33 7
Bison athabascae woods bison 2 3
Bison bonasus wisent 4 9
Bison priscus steppe bison 0 0
Bos sauveli kouprey 0 5
Bos frontalis mithun gayal 0 16
Bos gaurus gaur 0 17
Bos javanicus banteng 2 39
Bos taurus cattle 168 500
Bos primigenius aurochs 1 17
Bos indicus zebu 3 387
Bubalus bubalis water buffalo 4 342
Table 2. Informative derived characters of Bos taurus shared by Bos javanicus and Bos gaurus: amino acid variation at otherwise 
conserved sites that are fixed in all wild cattle sequences but differ from ancestral ruminant value (as exhibited in water buffalo, 
bison and yak). None of the sites support a sister relationship of any species of wild cattle to bison + yak to the exclusion of Bos 
taurus; no evidence lineage sorting was found. Bos frontalis and Bos sauveli are not included because of insufficient data.
Bos indicus Bos primigenius Bos javanicus Bos gaurus
Bos Bison Bos Bison Bos Bison Bos Bison
CYTB 4 0 4 0 4 0 4 0
ATP8 1 1 2 0 2 0 - -
ND5 14 0 14 0 14 0 - -
ND6 4 0 - - 4 0 - -
ND4L 2 0 - - 2 0 - -
ND3 0 0 0 0 0 0 - -
COX1 - - 1 0 1 0 - -
COX3 5 0 5 0 5 0 - -
COX2 2 0 2 0 2 0 2 0
ND2 5 0 5 0 5 0 - -
ND1 2 0 2 0 2 0 - -
ATP6 3 1 4 0 4 0 - -
ND4 8 0 8 0 8 0 - -
totals 50 1 47 0 47 0 6 0
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 Table 3. Bison non-sporadic mitochondrial protein variation. The first column provides GenBank accession, haplotype nomenclature 
(2) and bison provenance (YP: Yellowstone NP, BR: National Bison Refuge, MT: private Montana herd, EI: Elk Island NP, TX: 
Texas State Bison Herd, IT: Italian zoo). The second column provides multiplicity (number of bison with a given haplotype). The 
following columns provide the gene name and amino acid at a specified site (numbering relative to GU970004 proteins). V98A in 
CYTB (cytochrome b) and I60N in ATP6 are deleterious (see text).
Accession_Haplo_Loc mult CYTB ATP6 ATP6 ND5 ND4 ATP6 ND4 ATP8
GU947004_bHap17_YP 1 A98 N60 M182 H159 T314 A177 L442 E38
GU947001_bHap2__BR 11 A98 N60 M182 H159 T314 A177 L442 E38
GU947000_bHap10_FN 3 A98 N60 M182 H159 T314 A177 L442 E38
GU946994_bHap11_MT 1 A98 N60 M182 H159 T314 A177 L442 E38
GU946988_bHap8__MT 1 A98 N60 M182 H159 T314 A177 L442 E38
GU946979_bHap3__MT 2 V98 I60 T182 Y159 A314 A177 L442 K38
GU946998_bHap12_MT 1 V98 I60 T182 Y159 A314 A177 L442 K38
GU946980_bHap4__MT 1 V98 I60 T182 Y159 A314 A177 L442 E38
GU946985_bHap6__MT 1 V98 I60 T182 Y159 A314 A177 L442 E38
GU946989_bHap9__MT 2 V98 I60 T182 Y159 A314 A177 M442 E38
GU946982_bHap5__MT 1 V98 I60 T182 Y159 A314 A177 M442 E38
GU947006_wHap14_EI 1 V98 I60 T182 Y159 A314 A177 L442 E38
EU177871_bHapX__IT 1 V98 I60 T182 Y159 T314 A177 L442 E38
GU946987_bHap7__MT 1 V98 I60 T182 Y159 A314 A177 L442 E38
GU947002_bHap13_TX 2 V98 I60 T182 Y159 A314 T177 L442 E38
GU947003_bHap16_TX 1 V98 I60 T182 Y159 A314 T177 L442 E38
GU947005_wHap15_EI 1 V98 I60 T182 Y159 A314 T177 L442 E38
Table 4. Yak non-sporadic mitochondrial protein variation. The first column provides GenBank accession, haplotype nomenclature 
(grouped from those of reference 40 which also provides Tibetan location). The following columns provide the gene name and 
amino acid variation at a specified site (numbering relative to GQ464262 proteins). M383V is possibly sub-functional (see text).
Accession_Haplo ND2 ND2 ND4 ATP8 ND5 ND5 ND4L COX3 CYTB
GQ464262_hapA I29 S318 V398 S63 I62 M383 V17 V192 I192
GQ464261_hapA I29 S318 V398 S63 I62 M383 V17 V192 I192
GQ464257_hapA I29 S318 V398 S63 I62 M383 V17 V192 I192
GQ464251_hapA I29 S318 V398 S63 I62 M383 V17 V192 I192
GQ464250_hapA I29 S318 V398 S63 I62 M383 V17 V192 I192
GQ464249_hapA I29 S318 V398 S63 I62 M383 V17 V192 I192
GQ464260_hapB V29 P318 M398 L63 I62 M383 V17 V192 I192
GQ464266_hapB V29 P318 M398 L63 V62 V383 V17 V192 I192
GQ464263_hapB V29 P318 M398 L63 V62 V383 V17 V192 I192
GQ464259_hapB V29 P318 M398 L63 V62 V383 V17 V192 I192
GQ464264_hapB V29 P318 M398 L63 V62 V383 V17 V192 T192
GQ464246_hapB V29 P318 M398 L63 V62 V383 V17 V192 T192
GQ464253_hapB V29 P318 M398 L63 V62 V383 V17 V192 I192
GQ464252_hapB V29 P318 M398 L63 V62 V383 V17 V192 I192
GQ464247_hapB V29 P318 M398 L63 V62 V383 V17 V192 I192
GQ464255_hapB V29 P318 M398 L63 V62 V383 A17 V192 I192
GQ464254_hapB V29 P318 M398 L63 V62 V383 A17 V192 I192
GQ464265_hapB V29 P318 M398 L63 V62 V383 A17 V192 I192
GQ464248_hapB V29 P318 M398 L63 V62 V383 V17 I192 I192
GQ464258_hapB V29 P318 M398 L63 V62 V383 V17 I192 I192
GQ464256_hapB V29 P318 M398 L63 V62 V383 V17 I192 I192
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 Table 5. Reduced alphabet for each nsSNP determined by large-scale comparative genomics alignment. The first two rows provide 
mitochondrial gene name and variation relative to ancestral. The columns under each variant provide the abundances of other amino 
acids at that position in other ruminant data. The set of major alternative residues at a given site form its reduced alphabet; 
uncommon residues generally reflect sequence error or mutation (possibly somatic or heteroplasmic) in the individual chosen for 
sequencing but are sometimes adaptive or a clade-specific addition to the reduced alphabet.
CYTB ATP6 ATP6 ND5 ND4 ATP6 ND4 ATP8
V98A I60N T182M Y159H A314T A177T L442M E38K
4522 V 531 M 553 S 225 Y 281 A 998 A 221 L 215 E
430 I 392 I 286 M 73 H 8 T 88 T 46 I 34 K
34 M 106 T 98 T 5 I 4 S 19 M 17 S
11A 37 V 92 L 3 V 2 V 8 T 15 M
2 G 6 A 57 I 1 P 2 V 5 T
1 A 5 N 10 A 1 A 1 F 5 G
4 L 4 V 3 V
2 P 2 F 2 A
1 S 1 M
1 C
Table 7. Haplotype clustering by all-vs-all Blastn of all complete bison mitochondrial genomes. The first column provides global 
haplotypes using the terminology of reference 2; the second a reduced set of haplotypes defined in Table 7 by the control region 
diagnostic domain; the third a representative accession number. The fourth column gives multiplicities (example: first data row 
shows 11 complete mitochondrial genomes are identical to GU94700). The remaining columns show the number of base pair 
differences out of the 16,323 compared. Shading indicates blocks of closely related global haplotypes. The matrix is not quite 
symmetric because of gap alignment effects.
Haplo mHap Accession # U01 U04 U00 994 988 997 U06 982 980 871 985 987 992 998 U05 U02
BNBR1 hapA GU947001 11 0 2 3 4 4 20 21 21 22 22 25 25 26 26 23 23
BYNP1586 hapA GU947004 1 2 0 5 6 6 22 23 23 24 24 25 25 28 28 25 25
BFN5 hapA GU947000 3 3 5 0 1 1 19 20 20 21 21 24 24 25 25 22 22
B1031 hapA GU946994 1 4 6 1 0 2 20 21 21 22 22 25 25 26 26 23 23
B973 hapA GU946988 1 4 6 1 2 0 20 21 21 22 22 25 25 26 26 23 23
B1091 hapB GU946997 2 20 22 19 20 20 0 11 1 8 16 11 11 12 12 13 13
wElkI14 hapB GU947006 1 21 23 20 21 21 11 0 12 13 17 16 16 17 17 14 16
B897 hapB GU946982 1 21 23 20 21 21 1 12 0 9 17 12 12 13 13 14 14
B877 hapB GU946980 1 22 24 21 22 22 8 13 9 0 18 7 10 10 10 11 9
Euro hapB EU177871 1 22 24 21 22 22 16 17 17 18 0 21 21 22 22 19 21
B935 hapB GU946985 1 25 25 24 25 25 11 16 12 7 21 0 13 13 13 14 12
B961 hapB GU946987 1 25 25 24 25 25 11 16 12 10 21 13 0 14 14 15 15
B1018 hapB GU946992 2 26 28 25 26 26 12 17 12 10 22 13 14 0 1 15 15
B1191 hapB GU946998 1 27 26 24 25 25 13 18 14 11 23 14 15 1 0 16 16
wElk1 hapC GU947005 1 23 25 22 23 23 13 14 14 11 19 14 15 15 15 0 10
BTSBH1001 hapD GU947002 3 23 25 22 23 23 13 16 14 9 21 12 15 15 15 10 0
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Table 6. A. Phylogenetic conservation of ATP6 in a ten amino acid window about I60N. Light shading shows amino acids found in 
other mammals at greater than 1% frequency.  Dark shading indicates bison sequence (not always the highest frequency)>The 
neighborhood of I60N exhibits variable levels of conservation and no overt periodicity. The structure of the loop region containing 
I60N is thus not constrained by available data. B. Alignment against the only homologous protein with determined 3D structure (PDB 
1C17|M from E. coli) is not informative in the I60N region so the effect of the asparagine substitution cannot be modeled.
Phylogenetic Conservation of ATP6 in Neighborhood about I60N
55 56 57 58 59 60 61 62 63 64 65
K 1356 Q 1582 M 1011 M 1189 A 325 M 535 H 1083 N 1336 T 603 K 1151 G 1600
Q 161 H 13 L 515 F 126 S 238 P 525 L 414 S 197 K 212 G 212 A 11
N 37 N 12 I 75 I 7 L 196 I 391 I 72 T 38 P 193 N 54 S 5
H 19 E 11 V 17 T 4 M 92 T 108 V 29 G 21 Q 173 P 52 V 3
S 17 R 2 F 5 V 2 I 90 Q 35 M 24 D 17 L 107 Q 31 M 2
Y 12 Y 1 T 2 S 2 Q 58 V 9 T 1 H 6 H 71 T 28 T 1
G 10 T 1 Y 1 N 49 L 8 Q 1 P 4 V 54 A 28 P 1
R 6 Q 1 G 25 A 6 H 1 K 4 I 49 E 25 K 1
T 3 I 1 V 12 S 1 A 1 R 1 S 41 S 18 G 1
M 1 F 1 F 11 N 1 N 1 A 37 L 8 E 1
L 1 H 4 H 1 L 1 N 25 R 6
K 1 S 1 Y 24 M 4
I 1 R 1 M 14 I 3
E 1 R 13 D 2
A 1 F 4 K 1
E 3 H 1
P 2
Y 1
B. Alignment of bison ATP6 with homologous protein PDB 1C17|M from E. coli
                *                                                   
Bison: KQMMSNHNPKGQTWTLMLMLMSLILFIGSTNLLGLLPHSFTPTTQLSMNLGMA
                        L+ + L+ +I   ++LGL      P+  +++ L MA
Ecoli: PLALTIFVWVFLMNLMDLLPIDLLPYIAE-HVLGLPALRVVPSADVNVTLSMA
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Table 8. Predicting health status from control region haplotypes. The first column provides GenBank accession, the second the 
sequence of the diagnostic portion of the control region (positions 15894-15965 of Yellowstone bison GU947004), the third 
haplotype notation here, with columns four through six providing the observed or predicted amino acid of position 98 in cytochrome 
b and position 60 in ATP6. Column seven correlates diagnostic region haplotype with haplotype terminology of reference 2.  Light 
red: observed disease alleles; dark red: predicted disease. Light green: observed healthy alleles; dark green: predicted health. Other 
light/dark colors pairs show observed/predicted healthy alleles in less common haplotypes.
Accession TTGCAAACACCACTAGCTAACGTCACTCACCCCCAAAAATGCATTACCCAAACGGGGGGAAATATACATAAC Haplo Status CYTB ATP6 Haplo1
GU946996 C.....................................-................................. hapA observed 98A 60N bHap2
GU946995 C.....................................-................................. hapA observed 98A 60N bHap2
GU946981 C.....................................-................................. hapA observed 98A 60N bHap2
GU946976 C.....................................-................................. hapA observed 98A 60N bHap2
GU946983 C.....................................-................................. hapA observed 98A 60N bHap2
GU946984 C.....................................-................................. hapA observed 98A 60N bHap2
GU946993 C.....................................-................................. hapA observed 98A 60N bHap2
GU946986 C.....................................-................................. hapA observed 98A 60N bHap2
GU946977 C.....................................-................................. hapA observed 98A 60N bHap2
GU946978 C.....................................-................................. hapA observed 98A 60N bHap2
GU947001 C.....................................-................................. hapA observed 98A 60N bHap2
GU947004 C.....................................-................................. hapA observed 98A I60 bHap17
GU946991 C.....................................-................................. hapA observed 98A 60N bHap10
GU946990 C.....................................-................................. hapA observed 98A 60N bHap10
GU947000 C.....................................-................................. hapA observed 98A 60N bHap10
GU946994 C.....................................-................................. hapA observed 98A 60N bHap11
GU946988 C.....................................-................................. hapA observed 98A 60N bHap8
AY748509 C.....................................-................................. hapA predicted 98A 60N .....
AY748518 C.....................................-................................. hapA predicted 98A 60N .....
AF083362 C.....................................-................................. hapA predicted 98A 60N .....
AF083357 C.....................................-................................. hapA predicted 98A 60N .....
EF693810 C.....................................-................................. hapA predicted 98A 60N .....
U12948.. C.....................................-................................. hapA predicted 98A 60N .....
U12946.. C.....................................-................................. hapA predicted 98A 60N .....
U12945.. C.....................................-................................. hapA predicted 98A 60N .....
U12934.. C.....................................-................................. hapA predicted 98A 60N .....
U12933.. C.....................................-................................. hapA predicted 98A 60N .....
EU272058 C.....................................-................................. hapA predicted 98A 60N .....
EU272056 C.....................................-................................. hapA predicted 98A 60N .....
DQ452027 C.....................................-................................. hapA predicted 98A 60N .....
AY428859 C.....................................-................................. hapA predicted 98A 60N .....
GU946997 ......................................-...................--............ hapB observed V98 I60 bHap9
GU946989 ......................................-...................--............ hapB observed V98 I60 bHap9
GU947006 ......................................-...................--............ hapB observed V98 I60 wHap14
GU946982 ......................................-...................--............ hapB observed V98 I60 bHap5
GU946980 ......................................-...................--............ hapB observed V98 I60 bHap4
EU177871 ......................................-...................--............ hapB observed V98 I60 .....
GU946985 ......................................-...................--............ hapB observed V98 I60 bHap6
GU946987 ......................................-...................--............ hapB observed V98 I60 bHap7
GU946992 ......................................-...................--............ hapB observed V98 I60 bHap3
GU946979 ......................................-...................--............ hapB observed V98 I60 bHap3
GU946998 ......................................-...................--............ hapB observed V98 I60 bHap12
AY748745 ......................................-...................--............ hapB predicted V98 I60 .....
AY748477 ......................................-...................--............ hapB predicted V98 I60 .....
AY748530 ......................................-...................--............ hapB predicted V98 I60 .....
AY748519 ......................................-...................--............ hapB predicted V98 I60 .....
AY748630 ......................................-...................--............ hapB predicted V98 I60 .....
AY748495 ......................................-...................--............ hapB predicted V98 I60 .....
AY748693 .................................A....-...................--............ hapB predicted V98 I60 .....
AY748690 ......................................-...................--............ hapB predicted V98 I60 .....
AY748689 ......................................-...................--............ hapB predicted V98 I60 .....
AY748687 ......................................-...................--............ hapB predicted V98 I60 .....
AY748702 ......................................-...................--............ hapB predicted V98 I60 .....
AY748739 ......................................-...................--............ hapB predicted V98 I60 .....
AY748747 ......................................-...................--............ hapB predicted V98 I60 .....
AY748700 ......................................-...................--............ hapB predicted V98 I60 .....
AY748685 ......................................-................A..--............ hapB predicted V98 I60 .....
AY748678 ......................................-...................--............ hapB predicted V98 I60 .....
AY748676 ......................................-...................--............ hapB predicted V98 I60 .....
AY748677 ......................................-...................--............ hapB predicted V98 I60 .....
AY748701 ......................................-...................--............ hapB predicted V98 I60 .....
AY748680 ......................................-...................--............ hapB predicted V98 I60 .....
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AY748671 ......................................-...................--............ hapB predicted V98 I60 .....
AY748672 ......................................-...................--............ hapB predicted V98 I60 .....
AY748679 ......................................-...................--............ hapB predicted V98 I60 .....
AY748617 .........T............................-.......T...........--............ hapB predicted V98 I60 .....
AY748699 ......................................-...................--............ hapB predicted V98 I60 .....
AY748620 ...........................T..........-...................--............ hapB predicted V98 I60 .....
AY748748 ......................................-...................--............ hapB predicted V98 I60 .....
AY748742 ......................................-...................--............ hapB predicted V98 I60 .....
AY748758 ......................................-...................--............ hapB predicted V98 I60 .....
AY748757 ......................................-...................--............ hapB predicted V98 I60 .....
AY748618 ......................................-...................--............ hapB predicted V98 I60 .....
AF083364 ......................................-...................--............ hapB predicted V98 I60 .....
AF083363 ......................................-...................--............ hapB predicted V98 I60 .....
AF083360 ......................................-...................--............ hapB predicted V98 I60 .....
AF083361 ......................................-...................--............ hapB predicted V98 I60 .....
U12941.. ......................................-...................--............ hapB predicted V98 I60 .....
U12943.. ......................................-...................--............ hapB predicted V98 I60 .....
U12960.. ......................................-...................--............ hapB predicted V98 I60 .....
GU947005 ......................................-...................--...........T hapC observed V98 I60 wHap15
AY748478 ......................................-...................--...........T hapC predicted V98 I60 .....
AY748476 ..A...................................-...................--...........T hapC predicted V98 I60 .....
AY748695 ..............................T.......-...................--...........T hapC predicted V98 I60 .....
AY748675 ......................................-...................--...........T hapC predicted V98 I60 .....
AY748673 ......................................-...................--...........T hapC predicted V98 I60 .....
AY748674 ......................................-...................--...........T hapC predicted V98 I60 .....
AY748529 ......................................-...................--...........T hapC predicted V98 I60 .....
AF083359 ......................................-...................--...........T hapC predicted V98 I60 .....
U12959.. ......................................-...................--...........T hapC predicted V98 I60 .....
U12942.. ......................................-...................--...........T hapC predicted V98 I60 .....
U12937.. ......................................-...................--...........T hapC predicted V98 I60 .....
U12951.. ......................................-...................--...........T hapC predicted V98 I60 .....
GU946999 ......................................-...................-....G.......T hapD observed V98 I60 bHap13
GU947002 ......................................-...................-....G.......T hapD observed V98 I60 bHap13
GU947003 ......................................-...................-....G.......T hapD observed V98 I60 bHap16
AY748682 ..........................................................--............ hapE weak pred V98 I60 .....
AY748669 ..........................................................--............ hapE weak pred V98 I60 .....
AY748521 ..........................................................--............ hapE weak pred V98 I60 .....
AF083358 ..........................................................--............ hapE weak pred V98 I60 .....
AY748681 ......................................-...................-............. hapF weak pred 98A 60N .....
U12864.. ......................................-...................-............. hapF weak pred 98A 60N .....
Table 9. Sequence data of Gardipee (22) for Yellowstone and Grand Tetons National Parks. First and second columns provide herd 
locations. The third column shows number of bison carrying the disease haplotype; the fourth the numbers of bison with wildtype 
mitochondrial DNA. The final column shows the percentage of healthy bison varies with geographic location of the herds (which 
have little observed mixing).
Park Herd V98A I60N V98V I60I % Healthy
YNP Hayden Valley 88 6 6%
YNP Lamar Valley 19 22 54%
YNP Mirror Plateau 10 6 38%
GTNP Antelope Flats 20 0 0%
GTNP Wolf Creek 8 0 0%
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Figure 1. Structural models of the V98A region of bison cytochrome b adapted from previous crystallographic models of the bovine 
ortholog (57, 58). Here H97 is an axial ligand to heme iron and R100 forms a salt bridge to heme proprionate.
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